ST. CLAIR SHORES, Mich., Nov. 4, 2016 /PRNewswire/ -- As technology continues to become more integrated into the practice of medicine, its use in plastic and cosmetic surgery is becoming more relevant as well. Computer simulations for breast augmentation have been in the marketplace for some time with Vectra being one of the more popular technologies. Their system, however, involves patients standing on a large platform, surrounded by multiple cameras placed in different locations, which photographs them simultaneously from different angles. This then allows computer animations to be developed creating the implant simulations.
The latest advancement in this technology, developed by the Swiss company Crisalix, has taken this process a step further by eliminating the large platform with its multiple cameras and, through infrared scanning using an iPad, captures millions of data points through topographic infrared scanning allowing virtually instantaneous three-dimensional images to be produced. This data is then used to create the many implant simulations that the patient can view directly on a larger video screen.
The various implants sizes and styles from all existing U.S. implant companies can then be selected to allow each patient to see their appearance after surgery. Although this cannot guarantee a final outcome, as Dr. Melek Kayser comments, "It can certainly be helpful in either confirming what the patient may have already decided on previously, using implant sizers, or even allow her to realize that the size or shape of the implant that she initially selected may actually not be the best choice for her."
Another aspect to the program is its ability to estimate breast volume in patients who may desire an implant size change, removal or for those women who may be seeking breast reduction surgery as well. By subtracting the existing volume of an implant that a patient may already have, or even in women with larger breasts, a patient is able to see what her result may be. In addition, for patients who might present with breast ptosis or drooping, there are even tools that simulate a breast lift with scar placement as well. This technology can be particularly helpful in allowing breast reduction patients to estimate the amount of tissue that would be removed in surgery and help determine whether or not insurance coverage would even be applicable.
To further enhance the patient's experience, three dimensional imaging can then be seen through an iPhone or Android device attached to a virtual reality headset, allowing the patient to become fully immersed in images that show her reflected in virtual full length mirrors positioned throughout the virtual room allowing different views of herself to be seen. These are not simply static images but dynamic, adjusting to any changes in implant sizes or styles that are selected in the program itself.
Dr. Kayser has been utilizing this technology for nearly a year and has recently completed a full length video documenting a patient's progress from her initial consultation to her final six week result after breast augmentation.
Although this technology is not used to replace the consultation, Dr. Kayser states, "This technology is another opportunity to further enhance and refine the patient's experience. When combined with implant fittings, measurements, and of course, lengthy consultations that allow one on one personal contact with each of my patients, Crysalyx three-dimensional imaging technology has become an additional tool that helps patients to not only see what each implant will look like but to also achieve a more accurate outcome as well."
For more information about Dr. Kayser and his practice, please visit: https://www.imagebydesignmd.com.
This content was issued through the press release distribution service at Newswire.com. For more info visit: http://www.newswire.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/dr-melek-kayser-md-introduces-latest-3d-imaging-technology-for-breast-body-and-facial-animation-into-his-practice-300357849.html
SOURCE Dr. Melek Kayser MD